| Tag | Content |
|---|
EnhancerAtlas ID | HS116-17726 |
Organism | Homo sapiens |
Tissue/cell | Left_ventricle |
Coordinate | chr2:20235770-20236300 |
Target genes | |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| ELF5 | MA0136.2 | chr2:20236234-20236245 | ACCAGGAAGTA | + | 6.02 | | NKX2-3 | MA0672.1 | chr2:20235872-20235882 | ACCACTTGAA | + | 6.02 |
|
| | Number of super-enhancer constituents: 4 | ID | Coordinate | Tissue/cell |
| SE_00350 | chr2:20234871-20236506 | Adipose_Nuclei | | SE_10018 | chr2:20235383-20237387 | CD14 | | SE_14192 | chr2:20235841-20236569 | CD34_Primary_RO01549 | | SE_46219 | chr2:20235548-20237116 | Osteoblasts |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH02I020036 | chr2 | 20235823 | 20236647 |
|
Enhancer Sequence | GCTGTTTTTT TGATCTTCAT CTATAAACAA AAAGAAAAAC ACAGAAGGTG GAGCTCATGA 60
GGGAATGCTA TGCTAAGGGT TTTACTCAGA AGGCAGGGAG GCACCACTTG AAATTTCTCC 120
CCCGGAGATG ACATGAGCAG AGAGCCACAC AGAAGCCGCT GACCGTGGCT GACCAGGCCA 180
ACAGCCCTGC CCCTGGCCAC CTTTCTCCAG GCTTCCCCAC CCTCCCTCTG TGTGCCAGCC 240
ACCATGGCCA GCTTCTAGTG CCCTCACTAT GCTGCTTCTT GCCTCAAGGT CTCTCTTTTA 300
TCTGGAACAT TGTCTTCTAT ACTTTCTCTA TCTTAATTCC TGTTCAAACT CCTGAGTACA 360
ATTCAAATCT CACTTCCCAG CCCAGGTTTA GTACCCATGT GATATCCACT CCCACAGTAA 420
CCTACAATGG TGTATCAGTT AACTGTCAAC TTCCTGATTC CTTCACCAGG AAGTAAGCTC 480
CACTGATGCA TCTCTATGAC CTAGCAGAGT GCCTTGCACA TAAGAGCAAC 530
|
